| Cub Pharmacy 1640/768 | |
| 14075 Highway 13 S, Savage, Minnesota 55378 | |
| (952) 447-1611 |
| Name | Cub Pharmacy 1640/768 |
|---|---|
| Organization Name | Supervalu Pharmacies Inc |
| Location | 14075 Highway 13 S, Savage, Minnesota 55378 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (952) 447-1611 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.
Surgery, in addition to treatments like chemotherapy and radiation therapy, may increase the length of survival for metastatic breast cancer patients, according to Penn State College of Medicine and Penn State Cancer Institute researchers.
The U.S. Food and Drug Administration (FDA) is recommending the development of a vaccine to prevent the occurrence of pertussis (Whooping Cough) in adolescents.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.
› Verified 7 days ago
| NPI Number | 1457466591 |
| Organization Name | SUPERVALU PHARMACIES INC |
| Doing Business As | CUB PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 14075 Hwy 13 S, Savage, MN 55378 |
| Phone Number | 952-447-1611 |
News Archive
It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.
Surgery, in addition to treatments like chemotherapy and radiation therapy, may increase the length of survival for metastatic breast cancer patients, according to Penn State College of Medicine and Penn State Cancer Institute researchers.
The U.S. Food and Drug Administration (FDA) is recommending the development of a vaccine to prevent the occurrence of pertussis (Whooping Cough) in adolescents.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.
› Verified 7 days ago
News Archive
It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.
Surgery, in addition to treatments like chemotherapy and radiation therapy, may increase the length of survival for metastatic breast cancer patients, according to Penn State College of Medicine and Penn State Cancer Institute researchers.
The U.S. Food and Drug Administration (FDA) is recommending the development of a vaccine to prevent the occurrence of pertussis (Whooping Cough) in adolescents.
Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st American Society of Hematology Annual Meeting (ASH) to be held in New Orleans, LA ,December 5-8, 2009. An oral presentation will highlight results from an ongoing clinical Phase I monotherapy safety study in adults with acute myeloid leukemia (AML).
ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.
› Verified 7 days ago
Eagan Eye Clinic Llc Type: Medicare Supplier Location: 5809 Egan Dr, Savage, Minnesota 55378 Phone: (952) 226-2020 | |
Cvs Pharmacy #16954 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14333 Highway 13 S, Savage, Minnesota 55378 Phone: (952) 226-1442 | |
Hy-vee Pharmacy (1559) Type: Community/Retail Pharmacy Location: 6150 Egan Drive, Savage, Minnesota 55378 Phone: (952) 228-2552 | |
Target Optical #2096 Type: Eyewear Supplier (Equipment, not the service) Location: 14333 Highway 13 S, Savage, Minnesota 55378 Phone: (952) 226-1411 | |
Cub Pharmacy 1640/768 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 14075 Highway 13 S, Savage, Minnesota 55378 Phone: (952) 447-1611 |